TCL Archive In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease May 31, 1996
TCL Archive Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years May 9, 2014
TCL Archive Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS January 24, 2014
TCL Archive Senate Appropriations Include Cancer Control, Training Money, But Very Little for Construction July 8, 1988
TCL Archive Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results April 4, 1986
